JPMorgan Chase & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229M | Sell |
|
|||||
|
2025
Q1 | $382M | Sell |
|
|||||
|
2024
Q4 | $481M | Buy |
|
|||||
|
2024
Q3 | $644M | Buy |
|
|||||
|
2024
Q2 | $705M | Sell |
|
|||||
|
2024
Q1 | $722M | Buy |
|
|||||
|
2023
Q4 | $491M | Buy |
|
|||||
|
2023
Q3 | $188M | Buy |
|
|||||
|
2023
Q2 | $151M | Buy |
|
|||||
|
2023
Q1 | $146M | Sell |
|
|||||
|
2022
Q4 | $135M | Sell |
|
|||||
|
2022
Q3 | $112M | Buy |
|
|||||
|
2022
Q2 | $125M | Buy |
|
|||||
|
2022
Q1 | $87.2M | Buy |
|
|||||
|
2021
Q4 | $46.5M | Buy |
|
|||||
|
2021
Q3 | $35M | Sell |
|
|||||
|
2021
Q2 | $32.6M | Buy |
|
|||||
|
2021
Q1 | $24.7M | Buy |
|
|||||
|
2020
Q4 | $24.9M | Buy |
|
|||||
|
2020
Q3 | $24M | Sell |
|
|||||
|
2020
Q2 | $22.7M | Sell |
|
|||||
|
2020
Q1 | $28M | Sell |
|
|||||
|
2019
Q4 | $29.3M | Sell |
|
|||||
|
2019
Q3 | $29.1M | Sell |
|
|||||
|
2019
Q2 | $28.7M | Sell |
|
|||||
|
2019
Q1 | $30.1M | Sell |
|
|||||
|
2018
Q4 | $37.1M | Buy |
|
|||||
|
2018
Q3 | $33M | Sell |
|
|||||
|
2018
Q2 | $44.2M | Buy |
|
|||||
|
2018
Q1 | $32.1M | Buy |
|
|||||
|
2017
Q4 | $34.6M | Sell |
|
|||||
|
2017
Q3 | $32.7M | Buy |
|
|||||
|
2017
Q2 | $25.4M | Sell |
|
|||||
|
2017
Q1 | $28.8M | Sell |
|
|||||
|
2016
Q4 | $53.6M | Buy |
|
|||||
|
2016
Q3 | $48.1M | Buy |
|
|||||
|
2016
Q2 | $27.8M | Buy |
|
|||||
|
2016
Q1 | $23.7M | Sell |
|
|||||
|
2015
Q4 | $33M | Buy |
|
|||||
|
2015
Q3 | $27.7M | Buy |
|
|||||
|
2015
Q2 | $22.9M | Buy |
|
|||||
|
2015
Q1 | $16.9M | Buy |
|
|||||
|
2014
Q4 | $9.27M | Sell |
|
|||||
|
2014
Q3 | $11.1M | Buy |
|
|||||
|
2014
Q2 | $10.7M | Buy |
|
|||||
|
2014
Q1 | $9.01M | Buy |
|
|||||
|
2013
Q4 | $7.06M | Sell |
|
|||||
|
2013
Q3 | $35.5M | Sell |
|
|||||
|
2013
Q2 | $42.9M | Buy |
|